Descemet Membrane Endothelial Keratoplasty with Novel Infusi
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
A Study was conducted to describe a surgical technique of Descemet membrane endothelial keratoplasty (DMEK) using an endothelium-in pull-through technique with novel infusion forceps and report 6-month clinical outcomes.

33 cases with Fuchs endothelial corneal dystrophy who underwent either DMEK alone (n = 5), DMEK combined with phacoemulsification (n = 27), or DMEK combined with intraocular lens exchange (n = 1) performed by surgeons at the beginning of the DMEK learning curve were involved. Best-corrected visual acuity (BCVA), manifest refraction, central corneal thickness, endothelial cell density, intraoperative and postoperative complications, and need for additional surgeries including rebubbling were evaluated through 6 months postoperatively.

Results:
--Preoperative BCVA was 0.37 ± 0.34 logarithm of the minimum angle of resolution and improved to 0.09 ± 0.10 logarithm of the minimum angle of resolution at 6 months.

--82% of eyes obtained a BCVA of 20/25 or better. Central corneal thickness decreased significantly at 6 months.

--Endothelial cell loss was 29.1% at 6 months (available for 20 of 33 eyes). All surgeries were uneventful.

--6 eyes required rebubbling for graft detachments. There were no primary or secondary graft failures at 6 months.

Finally, DMEK with infusion microforceps is effective and secure in eyes with Fuchs endothelial corneal dystrophy, and it can provide a more regulated procedure, making it ideal for both inexperienced and experienced DMEK surgeons.

Source: https://journals.lww.com/corneajrnl/Abstract/2021/03000/Descemet_Membrane_Endothelial_Keratoplasty_Using_a.23.aspx
1 share
Like
Comment
Share